- Home
- BTMD vs SEER Comparison
BTMD vs SEER Comparison
Compare BTMD & SEER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BTMD
- SEER
- Stock Information
- Founded
- BTMD 2012
- SEER 2017
- Country
- BTMD United States
- SEER United States
- Employees
- BTMD N/A
- SEER N/A
- Industry
- BTMD Medicinal Chemicals and Botanical Products
- SEER Medicinal Chemicals and Botanical Products
- Sector
- BTMD Health Care
- SEER Health Care
- Exchange
- BTMD Nasdaq
- SEER Nasdaq
- Market Cap
- BTMD 127.8M
- SEER 125.3M
- IPO Year
- BTMD N/A
- SEER 2020
- Fundamental
- Price
- BTMD $4.02
- SEER $2.11
- Analyst Decision
- BTMD Strong Buy
- SEER Hold
- Analyst Count
- BTMD 1
- SEER 1
- Target Price
- BTMD $8.00
- SEER $3.00
- AVG Volume (30 Days)
- BTMD 119.6K
- SEER 127.0K
- Earning Date
- BTMD 08-07-2025
- SEER 08-07-2025
- Dividend Yield
- BTMD N/A
- SEER N/A
- EPS Growth
- BTMD 201.68
- SEER N/A
- EPS
- BTMD 0.60
- SEER N/A
- Revenue
- BTMD $199,379,000.00
- SEER $15,309,000.00
- Revenue This Year
- BTMD $5.87
- SEER $27.05
- Revenue Next Year
- BTMD $8.59
- SEER $28.33
- P/E Ratio
- BTMD $6.75
- SEER N/A
- Revenue Growth
- BTMD 6.44
- SEER N/A
- 52 Week Low
- BTMD $3.04
- SEER $1.59
- 52 Week High
- BTMD $8.35
- SEER $2.63
- Technical
- Relative Strength Index (RSI)
- BTMD 49.75
- SEER 49.50
- Support Level
- BTMD $3.92
- SEER $2.11
- Resistance Level
- BTMD $4.25
- SEER $2.17
- Average True Range (ATR)
- BTMD 0.21
- SEER 0.07
- MACD
- BTMD -0.02
- SEER -0.01
- Stochastic Oscillator
- BTMD 22.73
- SEER 15.38
About BTMD Biote Corp.
Biote Corp operates a growth practice-building business within the hormone optimization space. It provides the necessary components to enable Biote-certified practitioners to establish, build, and successfully implement a program designed to optimize hormone levels using personalized solutions for their patient populations. The company derives revenue from United States and also has its presence in other countries.
About SEER Seer Inc.
Seer Inc is a biotechnology company. The company commercializes transformative products for researchers to unlock deep, unbiased biological information. Its product, the Proteograph Product Suite (Proteograph), will leverage its proprietary engineered nanoparticle (NP) technology to provide unbiased, deep, rapid, and large-scale access across the proteome.